BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PDA Midwest - ECPv6.5.1.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PDA Midwest
X-ORIGINAL-URL:https://www.pdamidwest.org
X-WR-CALDESC:Events for PDA Midwest
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260422T183000
DTEND;TZID=America/New_York:20260422T193000
DTSTAMP:20260610T022221
CREATED:20260320T224336Z
LAST-MODIFIED:20260320T225114Z
UID:10000117-1776882600-1776886200@www.pdamidwest.org
SUMMARY:PDA Midwest Webinar: Radiopharma 101-An Introduction to Radiopharmaceuticals
DESCRIPTION:Radiopharma 101: An Introduction to Radiopharmaceuticals\n\n\n  \n\nHosted by the PDA Midwest Purdue Student Chapter\n\nOpen to All Students\nRadiopharmaceuticals are at the forefront of innovation in modern medicine—combining radioactive isotopes with biologically active molecules to diagnose\, monitor\, and treat disease. While nuclear medicine has been practiced for decades\, recent advances in targeted radionuclide therapies and theragnostic platforms have driven significant industry growth and renewed global investment. This rapid evolution has also increased regulatory focus worldwide.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbout the Presentation\n\nRadiopharma 101 provides a foundational overview of the radiopharmaceutical field\, designed for students interested in pharmaceutical science\, engineering\, microbiology\, quality\, manufacturing\, and regulatory affairs. \nThis presentation will explore: \n\nThe history and evolution of nuclear medicine\nMajor classes of diagnostic and therapeutic radiopharmaceuticals\nEmerging theranostic platforms and the diseases they target\nHow and where radiopharmaceuticals are manufactured\nThe unique challenges of producing time‑sensitive radioactive medicines\nAn overview of global regulatory expectations governing this rapidly growing industry\n\nAttendees will gain valuable insight into a specialized and expanding sector of pharmaceuticals\, making this session ideal for students considering careers in advanced therapies\, sterile manufacturing\, or regulatory science. \n  \nSpeaker\n\nKim Sobien\nSenior Microbiology Consultant\, ValSource\, Inc. \nKim brings over 25 years of pharmaceutical industry experience\, with deep expertise in microbiology\, sterility assurance\, contamination control\, aseptic processing\, investigations\, and inspection readiness. Her career spans a wide range of injectable products\, including radiopharmaceuticals\, biologics\, contract manufacturing\, and pre‑filled syringe generics. \nShe holds a BS in Microbiology from the University of Wisconsin–La Crosse and an MBA in Global Management from the University of Phoenix. Kim is an active leader within the Parenteral Drug Association (PDA)\, serving as: \n\nPresident‑Elect\, PDA Southeast Chapter\nCo‑Lead\, PDA EM/Microbiology Interest Group\nFormer Co‑Chair and Committee Member\, PDA Pharmaceutical Microbiology Conference\n\n  \nEvent Details\n\n\nDate: April 22\, 2026\nTime: 6:30 PM – 7:30 PM (EST)\nFormat: Live virtual webinar (Microsoft Teams)\nAudience: Open to all students\n\n\n\n\nRegistration\n\nWebinar registration is FREE\n\nRegister Now \n 
URL:https://www.pdamidwest.org/event/pda-midwest-webinar-radiopharma/
LOCATION:Virtual Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20251216T103000
DTEND;TZID=America/Chicago:20251216T114500
DTSTAMP:20260610T022221
CREATED:20251203T213657Z
LAST-MODIFIED:20251203T213657Z
UID:10000112-1765881000-1765885500@www.pdamidwest.org
SUMMARY:PDA Midwest Webinar: Advocating for Access – A Conversation with Angels for Change
DESCRIPTION:Advocating for Access – A Conversation with Angels for Changes\nJoin us for an inspiring and informative webinar featuring Laura Bray and Anthony Flammia\, leaders from Angels for Change\, a nonprofit organization committed to eliminating drug shortages and championing patient advocacy. During this session\, you’ll gain a deeper understanding of their mission to ensure equitable access to essential medications\, hear real-world stories that highlight the impact of their work on patients and healthcare systems\, and discover practical ways you can contribute to driving meaningful change. The event will include a comprehensive presentation followed by an interactive Q&A\, offering you the opportunity to engage directly with experts and explore solutions that make a difference in healthcare access.\n\n  \nPresentation Date and Time\n\nTuesday\, December 16\, 2025 from 10:30am to 11:45am (Central time zone) \n  \nPresentation\n\n  \nAdvocating for Access: Ending Drug Shortages Together \n\nDiscover how Angels for Change partners with patients\, healthcare providers\, and manufacturers to combat drug shortages and guarantee timely access to critical\, lifesaving medications. \n  \nFeatured Presenters: \n\nLaura Bray – Founder & CEO\, Angels for Change\nAnthony Flammia – Director of Advocacy\, Angels for Change\n\n \n\nRegistration\n\nWebinar registration is FREE\n\nRegister Now \n 
URL:https://www.pdamidwest.org/event/pda-midwest-webinar-advocating-for-access-a-conversation-with-angels-for-change/
LOCATION:Virtual Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241204T130000
DTEND;TZID=America/New_York:20241204T143000
DTSTAMP:20260610T022221
CREATED:20241108T142014Z
LAST-MODIFIED:20241108T142014Z
UID:10000106-1733317200-1733322600@www.pdamidwest.org
SUMMARY:Application of Essential Contamination Control Principles in Compounding Environments
DESCRIPTION:Application of Essential Contamination Control Principles in Compounding Environments\n\nJoin PDA Midwest Chapter for an insightful presentation featuring Michael T. Myers\, Clinical Support Manager\, Contec\, Inc.\, and Melanie Dorey\, R.Ph.T\, Owner/Consultant\, Critical Compounding Resources (Canada and US)\, as they explore the four essential contamination control principles through real-world case studies. This session will cover critical topics\, including hand hygiene and garbing\, material handling in compounding environments and then into ISO Class 5 environments\, operator conduct within the compounding environments\, and aseptic techniques within ISO Class 5 settings. To enhance your learning experience\, we will dedicate 30 minutes at the end for an interactive Q&A session. We encourage you to come prepared with questions related to effective contamination control strategies!  \nPresented by: Michael Myers\, Contec\, Inc\, and Melanie Dorey\, R.Ph.T\,  Critical Compounding Resources \n  \n\nPresentation Date and Time\n\n\nWednesday\, December 4\, 2024 @ 1:00pm (Eastern time zone)\n\n  \nPresenters – Bio\n\nMichael T Myers\, Clinical Support Manager\, Contec\, Inc.:\nMichael Myers brings a wealth of expertise and a longstanding dedication to Contec\, Inc.\, having joined the company in 1998. Throughout his tenure\, he has held various key positions\, including product development\, sales management\, and technical support. For over a decade\, Michael has demonstrated an unwavering commitment to the success of Sterile Compounding Pharmacies\, focusing on their specific needs and challenges. \nAs the Clinical Support Manager for Contec’s Healthcare division\, Michael plays a pivotal role in developing educational resources and conducting in-service training for pharmacy technicians. His mission is to equip them with the best practices for maintaining clean and disinfected environments in 503A compliant compounding pharmacies\, ensuring compliance with the stringent guidelines outlined in USP Chapters <797> and <800>. \nIn recognition of his outstanding contributions\, Michael was honored with the prestigious John Martin Outstanding New Member Award by the Institute of Environmental Sciences and Technology (IEST) in 2022. He holds a Bachelor of Science degree in Communications from Appalachian State University\, which further strengthens his ability to effectively communicate and provide valuable support to pharmacy professionals. \nWith his extensive experience\, industry knowledge\, and commitment to excellence\, Michael continues to drive innovation and foster the success of Sterile Compounding Pharmacies under the Contec Healthcare division. \nMelanie Dorey\, R.Ph.T\, Owner/Consultant\, Critical Compounding Resources:\n\nMelanie Dorey is a registered pharmacy technician and has worked in the compounding industry since 2006. She graduated from a 2-year Pharmacy Technician program in 2006 and at the Children’s Hospital of Eastern Ontario (CHEO) where she acquired a passion for sterile and nonsterile compounding. While attending the Sterile Compounding Boot Camp in Denver\, Colorado in 2007\, Melanie met several key industry experts who ignited her passion for sterile and nonsterile compounding. In 2014\, she joined the team at CriticalPoint and Kastango Consulting Group where she continued to hone her skills while developing eLearning\, standard operating procedures\, as well as in person and virtual lectures. She also traveled to client locations to perform competency assessment and customized training. Melanie has served on a variety of committees with NAPRA and the Ontario College of Pharmacy. Melanie is the owner of Critical Compounding Resources which offers services to compounding operations across North America. \n  \nRegistration\n\nThanks to our sponsor\, webinar registration is FREE\n\n  \n\nRegister Now \n 
URL:https://www.pdamidwest.org/event/application-of-essential-contamination-control-principles-in-compounding-environments/
LOCATION:Virtual Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20241114T110000
DTEND;TZID=America/Chicago:20241114T123000
DTSTAMP:20260610T022221
CREATED:20241029T203317Z
LAST-MODIFIED:20241031T004204Z
UID:10000105-1731582000-1731587400@www.pdamidwest.org
SUMMARY:Digital Enhancements for Pharma Operational Excellence
DESCRIPTION:Digital Enhancements for Pharma Operational Excellence\n\nIn this talk\, we will explore how cutting-edge generative AI technologies are driving operational excellence in the pharmaceutical industry. Through real-world examples\, we’ll discuss how large language models (LLMs) are automating summary documentation in commissioning testing\, drastically improving efficiency and reducing human error. We’ll dive into how GraphRAG is uncovering hidden trends and relationships in quality documentation\, enabling better decision-making and continuous improvement. Finally\, we’ll look at how large vision models and reality capture technology are transforming physical plants into fully contextualized digital replicas\, revolutionizing how facilities are managed and maintained. This is the future of pharma operations\, where AI not only enhances productivity but also drives a new standard of operational excellence. \n-Presented by Roger Ouimet\, CAI and Nick Armstrong\, Digital Enablement \n\n  \nPresentation Date and Time\n\n\nThursday\, November 14\, 2024 @ 11:00am (Central time zone)\n\n  \nPresenters – Bio\n\nRoger Ouimet\, Principal Consultant CAI:\nRoger is an experienced Program Manager and Owner Project Manager\, with extensive background in implementing small to large-scale expansion capital projects in Formulation\, Filling\, Packaging and QC Labs\, as well as across entire facilities for New Product Introduction and the associated Commissioning\, Qualification\, and Validation (CQV) deliverables and processes to support planning and execution. Additionally\, Roger spent 30 years Active and Reserve in the US Navy\, filling seven Command and additional unit\, staff and global leadership roles. As a Principal Consultant and Interim Director\, Program and Project Management\, he has launched QC Applications\, Manufacturing Execution System (MES) upgrades\, and a vial powder filling isolator product and process. He also delivered a new Project Management Office (PMO) and Operational Excellence programs for his clients. An active member of several PDA Interest Groups\, Roger contributed comments to the FDA and EMA on their draft guidance papers on AI in Drug Development and Drug Manufacturing\, and the Department of Homeland Defense’s draft law on Cyber Incident Reporting for Covered Entities.   \n\n  \nNick Armstrong\, Senior Director of Digital Enablement:\nNick is a seasoned leader with 15 years of experience as a process and reliability engineer in the pharmaceutical manufacturing industry. As Senior Director of Digital Enablement at CAI\, he leads the integration of advanced technologies like AI\, digital twin\, and augmented reality to enhance project delivery and drive operational excellence. He also spearheads research initiatives with external partners to push innovation in these areas.  In addition\, Nick serves as Co-Chair/Founder of the ISPE Artificial Intelligence Community of Practice\, where they help educate 22\,000 members on the applications of AI in life sciences and contribute to shaping industry guidelines for regulatory bodies like the FDA and EU regulators. \n\n  \nRegistration\n\nWebinar registration is FREE\n  \n\nRegister Now \n 
URL:https://www.pdamidwest.org/event/enhancing-operational-readiness-using-ai-technology/
LOCATION:Virtual Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240808T110000
DTEND;TZID=America/Chicago:20240808T123000
DTSTAMP:20260610T022221
CREATED:20240621T170838Z
LAST-MODIFIED:20240802T161023Z
UID:10000101-1723114800-1723120200@www.pdamidwest.org
SUMMARY:PDA Midwest/Missouri Valley Joint Virtual Event: Sterilization Conversion
DESCRIPTION:PDA Midwest/Missouri Valley Joint FREE Virtual Event: \nSterilization Conversion \nThe PDA Midwest and the Missouri Valley Chapters are pleased to present two speakers for our August 2024 event to focus on topics related to the medical device sterilization conversions to X-Ray sterilization from Gamma sterilization. \n\n\nPresentations\n\nSpeakers:  \nDr. Samuel Dorey\, Principal Scientist\, Materials & Irradiations Product Development\, Sartorius  \nFlorent Kuntz\, Strategic Development Manager\, Aerial \nTitle: X-Ray Sterilization Conversions \nAbstract: Case study presentation of a Gamma to X-Ray for sterilization conversion\, which discusses testing performed\, Dtser\, Dmax\, activation\, dosimetry and Monte Carlo simulation. \n\nSpeaker: Betty Howard\, Senior Radiation Sterilization Manager\, Steris Corporation \nTitle: Gamma to X-ray Conversions for sterilization of Healthcare Products \nAbstract: Sterilization of healthcare products are well documented with Radiation Technologies (Gamma X-ray and E Beam). Significant guidance is available in published standards\, seminars and other publications that make validation of dose\, and in most cases easy to document and support. The most widely used historically has been gamma with a smaller percentage of E Beam. As processing capacity needs grow and assurance of supplies of critical products are under pressure\, X-ray has become a greater consideration. X-ray has long been an option\, but access globally was not always available. As availability is growing\, we will discuss why X-ray is a viable alternative or addition to a sterilization portfolio\, show how gamma and X-ray compare (similarities and differences)\, and the basics of how converting from gamma to X-ray is achieved.\n \nPresentation Date / Time and Agenda\n\nThursday\, August 8\, 2024 @ 11:00am (Central time zone) \n11:00 AM      Opening/Event Overview \n11:05 AM      Sponsor Video \n11:07 AM      Presentation 1 \n11:37 AM:     Question and Answer Session for Speaker 1 \n11:52 AM      Presentation 2 \n12:12 PM:     Question and Answer Session for Speaker 2 \n12:28 PM      Closing remarks / upcoming events \nsponsorship opportunity\n\n  \nNamePriceBuy\nregistration\n\nWebinar registration is FREE: Thank you to our sponsor!
URL:https://www.pdamidwest.org/event/midwest_missouri/
LOCATION:Virtual Presentation
END:VEVENT
END:VCALENDAR